PGC expression levels were apparently up-regulated in hepatocellular carcinoma, prostate cancer, breast cancer, ovarian cancer, endometrial cancer, pancreatic cancer, kidney cancer, bladder cancer, eyelid basal cell carcinoma, squamous cell carcinoma and melanoma. This evidence concerns the gene PGC and prostate cancer.